trial · primary record
Bevacizumab HAI plus systemic chemotherapy
Hepatic Metastases
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 73 |
| Primary completion | 2025-03-13 |
| Primary endpoint | Relapse Free Survival/RFS |
| Registry ID | NCT00200200 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:22.603Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT00200200
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.